Australia PBS Adds RU486, Three Cancer Drugs To Subsidy List
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaceutical Benefits Scheme has decided to subsidize another $1 billion worth of drugs, including a controversial contraceptive and three costly cancer treatments.